Nanoblast, S.A.P.I. de C.V.

Nanoblast, S. A. P. I.

de C. V. specializes in developing advanced materials and regenerative medicine, integrating health and sustainability to deliver innovative solutions for various industries. Founded in 2014 and headquartered in Guadalajara, Mexico, Nanoblast focuses on advanced materials and regenerative medicine.

The firm has engaged in one investment deal, with its most recent fundraising occurring on June 1, 2017, from Angel Ventures. There is no indication of any notable changes in business strategy or operation since its inception. Nanoblast specializes in advanced materials and regenerative medicine, focusing on the intersection of health, sustainability, and innovation. Their core offerings include nano-engineered products designed to reinvent health care solutions and enhance environmental sustainability.

The company serves healthcare providers, research institutions, and environmental organizations, with products marketed primarily in North America and Europe. Nanoblast generates revenue through direct-to-consumer sales and business-to-business partnerships. The company’s transactions typically involve a structured pricing model that accommodates both individual consumers and institutional clients. Key products, particularly those related to advanced materials and regenerative medicine, are available through subscription services for ongoing access or one-time purchases for specific applications.

Ongoing partnerships with healthcare and environmental sectors support these revenue streams. As of June 1, 2017, Nanoblast raised venture funding from Angel Ventures. The firm aims to utilize this funding to enhance product development and expand its market reach. Upcoming products are being designed to cater to a growing demand for sustainable health solutions.

Additionally, there are plans to penetrate new geographic markets, with specific targets in North America and Europe by 2024.